Literature DB >> 9358693

Extinction of panicogenic effects of a 35% CO2 challenge in patients with panic disorder.

N B Schmidt1, J H Trakowski, J P Staab.   

Abstract

Inhalations of high concentrations of carbon dioxide (CO2) reliably produce panic attacks in patients with panic disorder. The present study evaluated whether cognitive-behavioral treatment (CBT) for panic disorder would extinguish CO2-induced panic and whether changes in panic and arousal-related cognitions were associated with the induction of panic. Patients with panic disorder (N = 54) were assigned to 1 of 3 experimental conditions: CBT with respiratory training (CBT-R), CBT without respiratory training (CBT), or delayed treatment. Participants received 5 repeated vital-capacity inhalations of 35% CO2/65% O2 prior to and following either 12 treatment sessions or a 12-week waiting period. During pretreatment assessments, 74% of patients experienced a panic attack during at least 1 inhalation. At posttreatment, only 20% of treated participants (CBT-R = 19%, CBT = 22%), compared with 64% of untreated participants, panicked. Forty-four percent of treated participants, compared with 0% of untreated participants, reported no anxiety during all posttreatment inhalations. Anxiety sensitivity as well as panic appraisals regarding the likelihood of panic and self-efficacy with coping with panic were significantly related to fearful responding to the CO2 challenge.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9358693     DOI: 10.1037//0021-843x.106.4.630

Source DB:  PubMed          Journal:  J Abnorm Psychol        ISSN: 0021-843X


  10 in total

1.  Ataques de nervios in relation to anxiety sensitivity among island Puerto Ricans.

Authors:  Jennifer A Cintrón; Michele M Carter; Tracy Sbrocco
Journal:  Cult Med Psychiatry       Date:  2005-12

2.  The Future of Intervention Science: Process-Based Therapy.

Authors:  Stefan G Hofmann; Steven C Hayes
Journal:  Clin Psychol Sci       Date:  2018-05-29

Review 3.  Hyperventilation in panic disorder and asthma: empirical evidence and clinical strategies.

Authors:  Alicia E Meuret; Thomas Ritz
Journal:  Int J Psychophysiol       Date:  2010-05-25       Impact factor: 2.997

4.  Catastrophic misinterpretations as a predictor of symptom change during treatment for panic disorder.

Authors:  Bethany A Teachman; Craig D Marker; Elise M Clerkin
Journal:  J Consult Clin Psychol       Date:  2010-12

5.  How effective are cognitive behavior therapies for major depression and anxiety disorders? A meta-analytic update of the evidence.

Authors:  Pim Cuijpers; Ioana A Cristea; Eirini Karyotaki; Mirjam Reijnders; Marcus J H Huibers
Journal:  World Psychiatry       Date:  2016-10       Impact factor: 49.548

6.  Understanding social anxiety as a risk for alcohol use disorders: fear of scrutiny, not social interaction fears, prospectively predicts alcohol use disorders.

Authors:  Julia D Buckner; Norman B Schmidt
Journal:  J Psychiatr Res       Date:  2008-06-10       Impact factor: 4.791

7.  Rapid tryptophan depletion following cognitive behavioural therapy for panic disorder.

Authors:  Caroline Bell; Sean Hood; John Potokar; Jon Nash; Mariona Adrover; Chris Frampton; Dana Hince; Ann Rich; Spilios Argyropoulos; David Nutt
Journal:  Psychopharmacology (Berl)       Date:  2009-10-13       Impact factor: 4.530

8.  Anxiety sensitivity profile: predictive and incremental validity.

Authors:  Norman B Schmidt; Meghan E Keough; Kiara R Timpano; J Anthony Richey
Journal:  J Anxiety Disord       Date:  2008-02-01

Review 9.  Psychological therapies for panic disorder with or without agoraphobia in adults: a network meta-analysis.

Authors:  Alessandro Pompoli; Toshi A Furukawa; Hissei Imai; Aran Tajika; Orestis Efthimiou; Georgia Salanti
Journal:  Cochrane Database Syst Rev       Date:  2016-04-13

10.  Genetic Biomarkers of Panic Disorder: A Systematic Review.

Authors:  Artemii Tretiakov; Alena Malakhova; Elena Naumova; Olga Rudko; Eugene Klimov
Journal:  Genes (Basel)       Date:  2020-11-04       Impact factor: 4.096

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.